Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is Viking Therapeutics Stock Really Going to $125?


Most veteran investors can attest that, although they're also often a complete bust, every now and then a biopharma stock dishes out a windfall gain.

That's what the analyst community seems to expect from Viking Therapeutics (NASDAQ: VKTX) in the foreseeable future. The stock's current consensus price target of $92.94 is more than 200% above the ticker's present price, while one analyst -- BTIG's Justin Zelin -- says this stock's worth $125. That's more than 300% above its current value.

The question is, what do so many stock-picking pros see in this extremely unprofitable pharmaceutical start-up?

Continue reading


Source Fool.com

Viking Therapeutics Inc Stock

€28.67
-1.420%
A loss of -1.420% shows a downward development for Viking Therapeutics Inc.

Like: 0
Share

Comments